Literature DB >> 21748111

Nodular Lymphocyte Predominant Hodgkin's Lymphoma Presenting as Severe Hypercalcaemia: A Case Report.

Ikram A Burney1, V Nirmala, Mansour S Al-Moundhri, Nicholas J Woodhouse.   

Abstract

Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) is a recently described type of Hodgkin's lymphoma (HL) and accounts for 5-6% of all the cases of HL. Here we report the case of an elderly man who presented to Sultan Qaboos University Hospital, Oman, with severe hypercalcemia, and was diagnosed to have stage IV NLPHL. Although the incidence of hypercalcemia is estimated to be between 1-5% in classical HL, to our knowledge this is the first report of NLPHL presenting with severe hypercalcemia. The patient responded to the anti-CD20 monoclonal antibody, Rituximab, and has been in clinical remission for more than 3 years.

Entities:  

Keywords:  Case Report; Hodgkin’s Lymphoma; Hypercalcemia; Monoclonal antibody; Oman; Rituximab; Thrombocytopenia

Year:  2007        PMID: 21748111      PMCID: PMC3074891     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  19 in total

1.  Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.

Authors:  R Karmali; S Barker; M Hewison; L Fraher; D R Katz; J L O'Riordan
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia.

Authors:  Gungor Utkan; Abdullah Buyukcelik; Bulent Yalcin; Ibrahim Tek; Hatice Doruk; Dilek Dincol; Selim Erekul; Meltem Baykara
Journal:  South Med J       Date:  2006-10       Impact factor: 0.954

3.  Hodgkin's disease presenting with hypercalcaemia of unknown origin.

Authors:  B Roca; E Simón
Journal:  Ir Med J       Date:  1998 May-Jun

4.  Hodgkin's disease with hypercalcemia detected by thallium-201 scintigraphy.

Authors:  R Linde; L Basso
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

Review 5.  Humoral hypercalcemia in Hodgkin's disease. Clinical and laboratory evaluation.

Authors:  J O Jacobson; F R Bringhurst; N L Harris; S A Weitzman; A C Aisenberg
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

6.  Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.

Authors:  Bradley C Ekstrand; Jennifer B Lucas; Steven M Horwitz; Zhen Fan; Sheila Breslin; Richard T Hoppe; Yasodha Natkunam; Nancy L Bartlett; Sandra J Horning
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

7.  Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease.

Authors:  J Bolo-Deoku; S Basu; S Lakhani; F Dunne; W A Ratcliffe; M Clarke; J L Barron
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

8.  Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma.

Authors:  Joseph D Khoury; Dan Jones; Marwan A Yared; John T Manning; Lynne V Abruzzo; Fredrick B Hagemeister; L Jeffrey Medeiros
Journal:  Am J Surg Pathol       Date:  2004-04       Impact factor: 6.394

9.  Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Authors:  Ludmila Boudová; Emina Torlakovic; Jan Delabie; Peter Reimer; Beate Pfistner; Sabine Wiedenmann; Volker Diehl; Hans-Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

Review 10.  Hypercalcemia and vitamin D metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?

Authors:  J W Rieke; S S Donaldson; S J Horning
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.